Sitemap

Merck donated 2.4 million RSD for medical and protective equipment in Serbia

More...

PPF Group To Sell A CETIN Group Stake To GIC

PPF Group and GIC have agreed that...

Serbian Government, Oracle Sign Memorandum Of Understanding

At the pavilion of the Republic of...

Bloomberg Adria To Start Operating In 2022

Bloomberg Media and Mtel Swiss – a...

Turkey To Declare 10 Ambassadors ‘Persona Non Grata’

The move means 10 ambassadors — including those of Germany and the United States — are now just one...

The Remote British Island That Remains Untouched By Covid

Alasdair and Gill Maclean say they felt a bit guilty having spent much of the past year happily living...

Western Balkans: Joint Statement of High Representative Josep Borrell and Secretary of State Antony Blinken

Following the recent meeting between EU High Representative Josep Borrell and U.S. Secretary of State Antony Blinken last week in...

Enlargement Package 2021 Adopted By The European Commission

Today, the European Commission adopted its 2021 Enlargement Package, providing a detailed assessment of the state of play and...

Serbia To Hold 5G Spectrum Auction In First Half Of 2022

AmCham and Ministry of Trade, Tourism and Telecommunications work together to tackle illicit trade online The 5G network and associated...

Globally Merck and the Jenner Institute developed a production platform that enables the mass production of a future vaccine. The joint team has reduced the development time of the production process from one year to two months.

“We have brought the future of vaccine production to the present,” said Merck’s executive board.

Merck, one of the world’s leading scientific and technological companies, has donated 2.4 million dinars to the Serbian health system, thus supporting the Government of Serbia’s efforts to address one of the biggest challenges faced today. The donation is realized in cooperation with UNICEF, it is intended for the procurement of medical and protective equipment for healthcare professionals, and today it was delivered in Serbia.

“We wanted to respond to what is currently most needed by the health care system in our country. Thanks to partners from UNICEF, we have directed assistance to the procurement of medical and protective equipment, currently essential for healthcare professionals, which is one of the priorities of the Ministry of Health. We want to thank all health care professionals for their commitment to protecting the health of the population,” said Ina Bulat, Merck’s CEO in Serbia.

UNICEF is fully supportive of national efforts to protect the population, primarily through the procurement of critically needed equipment for the health system. The number of companies and individuals who have responded to our call indicates that there is a strong awareness in Serbia that community is a force that can help us. I want to thank all the companies that donated to UNICEF to help us get rid of the coronary virus together and save lives in Serbia,” said Regina De Dominicis, Director of UNICEF in Serbia.

Merck is globally part of key initiatives to end the pandemic.

Merck and the Jenner Institute have announced that the foundation for mass production of Covid-19 ChAdOk1 nCoV-19 vaccine candidates has been laid. Over the last two years, Merck’s collaboration with the Jenner Institute has led to the development of a rapid platform that follows good manufacturing practices. The joint team reduced the production process development time from one year, as it would normally take, to just two months, thanks to a recently developed production platform.

Founded in November 2005 with the aim of developing innovative vaccines in partnership with Oxford University and the Pirbright Institute, the Jenner Institute has succeeded in developing Merck’s manufacturing process based on a previously generated platform, a key step in making the vaccine available as quickly as possible patients.

Also, on 26 March, Merck and the Bill & Melinda Gates Foundation, within a consortium of companies, announced an important collaboration to accelerate the development, production and delivery of vaccines, diagnostics and treatment for COVID-19.

In 2019, Merck was awarded the “Insight into the Future” prize of $1million for research into pandemic preparation, by Pardis Sabeti scientists at Harvard University and Broad and James Crow Institute at Vanderbilt University. With their teams, today, thanks to the Merck Award, they are working to identify the diagnosis and treatment for COVID-19.

Related Articles

FDA Panel Backs COVID-19 Boosters Only For Elderly And High-Risk

Dealing the White House a stinging setback, a US government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across...

CCIS and UNICEF Reaffirm Partnership to Promote Children’s Rights

The Chamber of Commerce and Industry of Serbia (CCIS) and the United Nations Children's Fund Serbia (UNICEF) have signed today a new Memorandum of...

United States Donates Five More Ambulances To Healthcare Institutions In Serbia

Five fully equipped ambulances are on their way to Serbian healthcare institutions to help them respond effectively to the COVID-19 pandemic, as well as...

Third Shipment Of COVID-19 Vaccines Procured Through The COVAX Facility Arrives In Serbia

Serbia has received a new shipment of COVID-19 vaccines procured through the COVAX Facility. The third delivery of 115,200 doses of the AstraZeneca vaccines...

Coronavirus: Thousands Protest Against Restrictions Across Europe

The protesters are angered by health passes and mandatory vaccinations, as they believe those policies curtail freedom. European governments are ramping up pressure on...

UN report: Pandemic Year Marked By Spike In World Hunger

Africa posting biggest jump. World at critical juncture, must act now for 2030 turnaround There was a dramatic worsening of world hunger in 2020, the...

Nebojša Škuljec, Director, Merck Sharp & Dohme

Committed To Patients’ Health In Serbia

For 130 years, Merck Sharp & Dohme has been inventing for life, bringing medicines and vaccines for many of the world’s most challenging diseases...

Over 50000 Vaccines Arrived To Serbia With EU Support

Today 50,400 vaccines of AstraZeneca vaccine donated by Romania have arrived on Nikola Tesla airport and were later brought to the Torlak Institute. The...